FindTrial
Sign In

Modified needle technique for the treatment of Dupuytren’s disease and assessing its functional outcome

Functional outcome of modified percutaneous needle aponeurotomy for Dupuytren’s disease - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/07/070405
Enrollment
23
Registered
2024-07-10
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M720- Palmar fascial fibromatosis [Dupuytren]

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Dr Navaneeth P K
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Symptomatic MCP joint contracture with a palpable cord (not beyond stage 2 Tubiana), 2)PIP joint contracture less than 15 degrees, 3)Compliant patient

Exclusion criteria

Exclusion criteria: 1)Severe PIP joint contracture, 2)Skin shortage, scarring , tight skin, 3)Aggressive systemic disease, 4)Non-compliant patient

Design outcomes

Primary

MeasureTime frame
Quick DASH Score, URAM Scale and range of motion of the affected fingersTimepoint: 6 months—

Secondary

MeasureTime frame
Recurrent rateTimepoint: 1 year;Secondary outcomes will include a safety assessment, as judged by incidence rate and severity of adverse effects (eg, pain or limited activity)Timepoint: 1 year—

Countries

India

Contacts

Public ContactDr Anil K Bhat

KMC Manipal, MAHE Manipal

anil.bhat@manipal.edu9008419336

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026